PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Trial of bivalirudin during angioplasty reports mixed results

Anticoagulant fails to meet primary endpoints but may reduce bleeding and death

2015-03-17
(Press-News.org) Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints--a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding--as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session. However, bivalirudin was associated with significantly lower rates of bleeding complications and death, two of the study's secondary endpoints.

Study authors said the reason the study did not meet its co-primary composite endpoints is likely related to the high prevalence of heart attacks, which occurred in about 8.5 percent of patients in both groups and likely diluted the benefits reflected in the rates of death and bleeding. In addition, the study had a higher-than-usual bar for statistical significance due to its inclusion of two co-primary endpoints instead of only one.

Patients in the control group were given the widely used anticoagulant unfractionated heparin, as well as glycoprotein IIb/IIIa inhibitors, another class of anticoagulants, at the physician's discretion.

"We saw an impressive reduction in bleeding with bivalirudin compared to the control, which likely contributed to the reduced mortality in this group," said Marco Valgimigli, M.D., Ph.D., associate professor of cardiology and senior interventional cardiologist at the Erasmus University Medical Center in the Netherlands and the study's lead author. "I believe the study shows bivalirudin can provide additional benefits to patients as compared to unfractionated heparin in current medical practice."

Angioplasty is performed to clear blocked arteries in more than 1 million people in the United States each year. Patients are given anticoagulants to prevent the formation of dangerous blood clots during the procedure.

The study, called the Minimizing Adverse Hemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX Program (MATRIX), randomized more than 7,200 patients undergoing angioplasty at 78 hospitals in four European countries to bivalirudin or standard coagulation therapy. All participants had acute coronary syndrome, a condition that includes the two types of heart attack--ST-elevation myocardial infarction and non-ST elevation myocardial infarction--or unstable angina, a type of severe chest pain that is due to the buildup of plaque in the heart's arteries.

Bivalirudin was associated with a significantly lower rate of death, which occurred in 1.7 percent of patients receiving bivalirudin and 2.3 percent of patients in the control group. This reduction is likely the result of a significantly lower rate of bleeding complications, seen in 1.4 percent of patients receiving bivalirudin and 2.5 percent of patients in the control group, Valgimigli said. The difference in bleeding complications was especially pronounced for bleeding beyond that near the catheter insertion site, a more dangerous complication than bleeding that is confined to the catheter insertion site.

The study comes on the heels of a series of controversial and inconsistent bivalirudin trials. In a key departure from its predecessors, the MATRIX trial allowed interventional cardiologists to decide whether to give glycoprotein IIb/IIIa inhibitors as a complement to unfractionated heparin in control patients, whereas previous studies either required or forbade the use of these drugs. Glycoprotein IIb/IIIa inhibitors are widely used by U.S. surgeons and rarely used in Europe, so neither requiring nor forbidding the use of these drugs is an accurate reflection of a real-world setting in which these drugs are used part of the time.

"Our study really comes at the right moment to re-evaluate the role of bivalirudin," Valgimigli said. "Glycoprotein IIb/IIIa inhibitors were used in about one-quarter of the control patients in our study, at the operator's discretion, which is a better reflection of current practice than the control protocol used in previous studies." Glycoprotein IIb/IIIa inhibitors were allowed only as a backup strategy for patients randomized to receive bivalirudin.

In addition, the new trial randomized patients to receive their angioplasty via a catheter inserted in an artery in either the arm or the groin, thus accounting for the potential effects different catheter access points may have had on the results of previous studies. The effects of bivalirudin were consistent regardless of whether patients received their catheter in the arm or the groin.

An important aspect of the study is that participants had a higher-than-expected rate of adverse events due to their high risk profile. This speaks to the fact that patients were representative of the typical population being treated in current practice and unlike many other studies, high risk patients were not excluded from participating in the study.

The study is limited in that it relied on a composite endpoint and it was not powered for mortality or major bleeding alone.

MATRIX investigators are separately reporting results related to catheter access site. In addition, analysis is ongoing to investigate potential effects of the length of bivalirudin administration. Those results will be reported at a later date.

INFORMATION:

The study was funded by the Gruppo Italiano Studi Emodinamica (Italian Society of Interventional Cardiology), which received research grants from the Medicines Company, the maker of bivalirudin, and the medical device company Terumo. The study was independently designed and conducted by Valgimigli and co-investigators.

The ACC's Annual Scientific Session brings together cardiologists and cardiovascular specialists from around the world each year to share the newest discoveries in treatment and prevention. Follow @ACCMediaCenter and #ACC15 for the latest news from the meeting.

The American College of Cardiology is a 49,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.



ELSE PRESS RELEASES FROM THIS DATE:

Arm is safer access point than groin for catheter-based heart procedures

2015-03-17
SAN DIEGO (March 16, 2015) -- Patients with acute coronary syndrome undergoing coronary angiogram, a procedure used to assess blockages in the heart's arteries, had a significantly lower risk of major bleeding and death if their interventional cardiologist accessed the heart through an artery in the arm rather than the groin, according to research presented at the American College of Cardiology's 64th Annual Scientific Session. Study authors said the results should prompt a re-evaluation of clinical guidelines and that the arm, currently used in a minority of cases in the ...

UNC-Chapel Hill researchers collaborate to develop revolutionary 3-D printing technology

2015-03-17
A 3D printing technology developed by Silicon Valley startup, Carbon3D Inc., enables objects to rise from a liquid media continuously rather than being built layer by layer as they have been for the past 25 years, representing a fundamentally new approach to 3D printing. The technology, to appear as the cover article in the March 20 print issue of Science, allows ready-to-use products to be made 25 to 100 times faster than other methods and creates previously unachievable geometries that open opportunities for innovation not only in health care and medicine, but also in ...

Study reveals previously unknown site of anesthetic action

2015-03-17
Anesthetics have been used in surgical procedures for more than 150 years, but the mechanisms by which inhaled anesthesia actually work are poorly understood. Now, researchers at Johns Hopkins Medicine have discovered that anesthetics bind to and interfere with certain proteins in excitatory neurons, which are necessary for these neurons to transmit signals involved in anesthesia and the perception of pain. "Our discovery may be an important component of the mechanism of anesthesia and -- because this particular protein is also involved in neuronal development -- could ...

Joint fluid harbors bacterial clumps after replacement despite pre-surgery antibiotics

2015-03-17
PHILADELPHIA, PA - March 17, 2015- Researchers at Thomas Jefferson University and the National Institutes of Health are building on their research which seeks to understand why joint infections persist despite standards of care designed to stop them. More Americans than ever will receive joint replacements, and with an infection rate of approximately 1 percent, the potential exists for tens of thousands to experience post-operative infection and complications each year. "In this study, we decided to find out if pre-operative, prophylactic antibiotic concentrations in ...

Emerging diseases likely to be more harmful in similar species

2015-03-17
When viruses such as influenza and Ebola jump from one species to another, their ability to cause harm can change dramatically, but research from the University of Cambridge shows that it may be possible to predict the virus's virulence by looking at how deadly it is in closely-related species. A number of emerging infectious diseases - including some of the most deadly outbreaks such as Ebola, SARS and HIV - are the result of humans becoming infected with a pathogen that normally infects another species. The amount of harm caused by a pathogen when it jumps into a new ...

Meta-analysis finds extended DAPT related to increased mortality after DES implantation

2015-03-17
NEW YORK, NY - March 13, 2015 - Data from a meta-analysis published today in The Lancet found that extended duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was associated with significantly higher rates of mortality compared to shorter DAPT. The optimal duration of DAPT has been a matter of debate since the introduction of DES. A meta-analysis using multiple analytical approaches to investigate mortality and other clinical outcomes with different DAPT strategies was conducted. Researchers examined 31,666 patients from 10 randomized ...

Findings from the BRIGHT trial published in JAMA

2015-03-17
NEW YORK, NY - March 16, 2015 - Data from the BRIGHT trial published today in the Journal of the American Medical Association demonstrated that bivalirudin was superior to both heparin monotherapy and heparin plus tirofiban for patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). Findings were first reported at last year's Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). There has been recent controversy surrounding the optimal anticoagulant ...

What's on the menu for young African sawflies?

Whats on the menu for young African sawflies?
2015-03-17
Sawflies belong to the same insect group as wasps, bees and ants. Unlike many of the latter, sawflies seldom make themselves conspicuous to humans, although the young stages (larvae) of some species, nearly all of which feed on plants, sometimes attract attention by damaging these. In a reversal of the pattern found in most insect groups, a larger number of sawfly species occur in regions with a cooler climate, rather than in the tropics. On the other hand, many of the sawflies found in Africa south of the Sahara (the Afrotropical faunal region) belong to genera that ...

Heart valve repair improves emotional wellbeing in patients with mitral regurgitation

2015-03-17
Chicago, March 17, 2015 - Patients with severe mitral regurgitation (MR) often suffer from psycho-emotional symptoms, such as depression and anxiety, but after undergoing mitral valve repair surgery patients experience a marked improvement in emotional and physical wellbeing, according to an article in the March 2015 issue of The Annals of Thoracic Surgery. Key points Patients with severe mitral regurgitation, who had suffered from anxiety and post-traumatic stress symptoms prior to mitral valve surgery, experienced a marked improvement in emotional and physical ...

By land and by sea: Scientists find differences in tanning treatments for materials

2015-03-17
Cod liver oil and willow bark extract used in the tanning of skins for clothing and other products offer notable differences in treatment, a study by a team of scientists shows. Their findings show the promise of a technique that may be used to identify the aging behavior of materials and to examine delicate works of art. The research, which appears in the journal Analytical Chemistry, relies on a method employing nuclear magnetic resonance spectroscopy, or NMR spectroscopy, which reveals the physical and chemical properties of atoms in a given substance, as well as the ...

LAST 30 PRESS RELEASES:

Heat and heavy metals are changing the way that bees buzz

What’s behind the enormous increase in early-onset gastrointestinal cancers?

Pharmacogenomics expert advances precision medicine for bipolar disorder

Brazilian researcher explores centenarian stem cells for aging insights

Dr. Xuyu Qian's breakthrough analysis of 18 million brain cells advances understanding of human brain development

Gene networks decode human brain architecture from health to glioma

How artificial light at night damages brain health and metabolism

For ultrasound, ultra-strength not always a good thing

Matching your workouts to your personality could make exercising more enjoyable and give you better results

Study shows people perceive biodiversity

Personality type can predict which forms of exercise people enjoy

People can accurately judge biodiversity through sight and sound

People diagnosed with dementia are living longer, global study shows

When domesticated rabbits go feral, new morphologies emerge

Rain events could cause major failure of Waikīkī storm drainage by 2050

Breakthrough in upconversion luminescence research: Uncovering the energy back transfer mechanism

Hidden role of 'cell protector' opens cancer treatment possibilities

How plants build the microbiome they need to survive in a tough environment

Depression due to politics and its quiet danger to democracy addressed in new book 'The Sad Citizen'

International experts and patients unite to help ensure all patients are fully informed before consenting to new surgical procedures

Melting glaciers could trigger more explosive eruptions globally, finds research

Nearly half of U.S. grandchildren live within 10 miles of a grandparent

Study demonstrates low-cost method to remove CO₂ from air using cold temperatures, common materials

Masonic Medical Research Institute (MMRI) welcomes 13 students to prestigious Summer Fellowship program

Mass timber could elevate hospital construction

A nuanced model of soil moisture illuminates plant behavior and climate patterns

$2.6 million NIH grant backs search for genetic cure in deadly heart disease

Pennsylvania’s medical cannabis program changed drastically when anxiety was added as a qualifying condition

1 in 5 overweight adults could be reclassified with obesity according to new framework

Findings of study on how illegally manufactured fentanyl enters U.S. contradict common assumptions, undermining efforts to control supply

[Press-News.org] Trial of bivalirudin during angioplasty reports mixed results
Anticoagulant fails to meet primary endpoints but may reduce bleeding and death